About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Rheumatoid Arthritis Clinical Trials in New York | 3,596 Studies | Clareo Health

Clinical Trials Rheumatoid ArthritisNew York

Rheumatoid Arthritis Clinical Trials in New York

Find 3,596 clinical trials for rheumatoid arthritis near New York, New York. Connect with research centers in your area.

All Rheumatoid Arthritis trials nationwide All trials in New York

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 3381-3400 of 3,596 trials

COMPLETEDPhase 2< 1 mile

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001 in subjects with ALS.

Amyotrophic Lateral Sclerosis

Neuraltus Pharmaceuticals, Inc.136 participantsStarted Feb 2011

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +14 more locations

COMPLETEDPhase 3< 1 mile

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

NCT00542685

This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.

Generalized Anxiety Disorder

Pfizer551 participantsStarted Oct 2007

Beverly Hills, California, United States • Encino, California, United States • National City, California, United States +40 more locations

Rheumatoid Arthritis Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TERMINATEDPhase 3< 1 mile

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

NCT00658008

This is a 10-week trial that evaluates the efficacy and safety of PD 0332334 in subjects, ages from 18 to 65, with generalized anxiety disorder.

Generalized Anxiety Disorder

Pfizer501 participantsStarted Apr 2008

Litchfield Park, Arizona, United States • Costa Mesa, California, United States • Pasadena, California, United States +49 more locations

COMPLETEDNA< 1 mile

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

NCT00000666

To evaluate pyrimethamine as a prophylactic agent against toxoplasmic encephalitis in individuals who are coinfected with HIV and latent Toxoplasma gondii. Toxoplasmic encephalitis is a major cause of illness and death in AIDS patients. Standard treatment for toxoplasmic encephalitis is to combine pyrimethamine and sulfadiazine. Continuous treatment is necessary to prevent recurrence of the disease, but constant use of pyrimethamine/sulfadiazine is associated with toxicity. Clindamycin has been shown to be effective in treatment of toxoplasmic encephalitis in animal studies. This study evaluates pyrimethamine as a preventive treatment against toxoplasmic encephalitis (per 3/26/91 amendment, clindamycin arm was discontinued).

Toxoplasmosis, CerebralHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)600 participants

San Francisco, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +13 more locations

COMPLETEDNA< 1 mile

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

NCT00000883

The purpose of this study is to see if there are any changes in sugar and fat levels in the blood when patients take anti-HIV therapy for many years. Another goal is to test memory and mental concentrations to determine if anti-HIV drugs protect the brain from damage caused by HIV. (The purpose of this study has been changed from the original version.) HIV-infected patients with low CD4 cell counts are at risk for getting opportunistic (AIDS-related) infections. CD4 cells are cells of the immune system that help fight infection. Anti-HIV therapy may increase CD4 counts, which may lead to a decrease in AIDS-related infections. Problems that anti-HIV therapy is associated with include metabolic problems, neurologic problems, abnormal opportunistic infections, and cancer. Patients in ACTG 362 have been exposed to anti-HIV therapy longer than any other large group in the ACTG. These patients appear to benefit from their therapy, but also suffer problems from it. Observation of these patients should provide more information about long-term anti-HIV treatment and may detect unexpected problems. (This study as been changed. More information about the reasons for conducting this study has been added.)

Mycobacterium Avium-intracellulare InfectionHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)636 participantsStarted Oct 1997

Birmingham, Alabama, United States • Los Angeles, California, United States • Menlo Park, California, United States +48 more locations

COMPLETEDPhase 1/2< 1 mile

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate

NCT00489840

Investigation to evaluate Anecortave Acetate in the treatment of chronic central serous chorioretinopathy

Chronic Central Serous Chorioretinopathy

Manhattan Eye, Ear & Throat Hospital5 participantsStarted May 2007

New York, New York, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole

NCT00211393

The purpose of this study is to determine the effect of an adrenocorticoid antagonist (ketoconazole), 600 mg per day for 4 weeks, in the treatment of patients with central serous chorioretinopathy (CSC).

Chronic Central Serous Chorioretinopathy

Manhattan Eye, Ear & Throat Hospital5 participantsStarted May 2005

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

NCT00211458

The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control classic neovascularization following failure of treatment with photodynamic therapy using Visudyne.

Macular Degeneration

Manhattan Eye, Ear & Throat HospitalStarted Sep 2005

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age

NCT00488345

To determine the pharmacokinetic profile and to evaluate the safety and tolerability of ascending multiple doses of tigecycline in patients aged 8 to 11 years with selected serious infections; complicated intra-abdominal infections (cIAI), complicated skin and skin structure infections (cSSSI), or community-acquired pneumonia (CAP).

Bacterial InfectionsIntra-Abdominal InfectionPneumonia, Bacterial+2 more

Wyeth is now a wholly owned subsidiary of Pfizer59 participantsStarted Dec 2007

Long Beach, California, United States • Oakland, California, United States • Orange, California, United States +33 more locations

TERMINATEDPhase 2< 1 mile

Belatacept in Liver Transplant Recipients

NCT00555321

The purpose of this clinical research study is to evaluate the effects of belatacept, relative to tacrolimus, on the incidence of rejection, graft loss and death in subjects receiving a liver transplant

Immunosuppression in Solid Organ Transplant

Bristol-Myers Squibb260 participantsStarted Jan 2008

Phoenix, Arizona, United States • Los Angeles, California, United States • San Francisco, California, United States +39 more locations

TERMINATEDPhase 3< 1 mile

Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk

NCT00447187

This was a pivotal trial to determine whether LX201 reduces the likelihood of a graft rejection episode following corneal transplantation in patients at high immunological risk for rejection.

Corneal DiseasesCornea Transplant

Lux Biosciences, Inc.368 participantsStarted Apr 2007

Phoenix, Arizona, United States • Loma Linda, California, United States • Los Angeles, California, United States +27 more locations

COMPLETEDPhase 2< 1 mile

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00014144

RATIONALE: Biological therapies such as ZD 1839 may interfere with the growth of the tumor cells and slow the growth of cancer of the urinary tract. PURPOSE: Phase II trial to study the effectiveness of ZD 1839 in treating patients who have advanced cancer of the urinary tract.

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer

SWOG Cancer Research Network31 participantsStarted Feb 2001

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +92 more locations

COMPLETEDNA< 1 mile

Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

NCT00448981

Colds and flu cause much loss of work and school. The purpose of this study is to try to reduce the transmission of colds and flu among household members with one of three interventions: some educational material, educational material and use of alcohol hand sanitizers, and educational material and use of alcohol hand sanitizers as well as face masks when somebody has symptoms of the flu. We will recruit 450 households in Northern Manhattan and each household will be randomly assigned to one of these three groups. We will then follow these households for 15 months to see how often they get cold and flu symptoms. We will also look at antibiotic use practices for symptoms of colds and influenza ; household member knowledge of prevention and treatment strategies for pandemic influenza and viral URIs; and rates of influenza vaccination among household members. When someone in the study has serious flu symptoms such as a high fever and cough or sore throat, we will also obtain a nasal culture (by swabbing the nose) to see if there is flu virus present.

Respiratory Tract InfectionsCommon Cold

Centers for Disease Control and Prevention2,788 participantsStarted Nov 2006

New York, New York, United States

COMPLETEDPhase 312 miles

FS VH S/D 500 S-apr in Vascular Surgery

NCT00892957

The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.

Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses

Baxter Healthcare Corporation176 participantsStarted Jul 2009

Birmingham, Alabama, United States • Tucson, Arizona, United States • Fresno, California, United States +19 more locations

COMPLETEDPhase 328 miles

An Implantable Spinal Cord Stimulation Pain Management System

NCT00205855

There are many treatment options available for the management of chronic pain . Some include, but are not limited to, over-the-counter medications, Non-Steroidal Anti-Inflammatory Drugs, Physical Therapy, Transcutaneous Electrical Nerve Stimulation (TENS) and nerve blocks. Historically, the mainstay of pain treatment has been pharmacotherapy. However, pharmacotherapy has varying degrees of effectiveness and is often associated with undesirable side effects. Although many patients are successfully treated, for those who fail some of these more conservative therapies the remaining option is limited to spinal cord stimulation (SCS), proven to be an effective therapy to more than half of those failing conservative treatments . Over 50% of those who have failed these more conservative methods of pain management, can now, under the guidance of a clinician utilizing SCS, have their pain levels successfully managed. SCS is a less invasive therapy that is a reversible treatment with greater long-term benefits than more permanent, radical approaches and one that deserves greater consideration in the management of chronic, intractable pain.

Chronic PainPain, IntractablePain+2 more

Boston Scientific Corporation65 participantsStarted Feb 2003

Huntsville, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +6 more locations

COMPLETEDPhase 234 miles

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

NCT00293657

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Headache (Migraine)

POZEN150 participantsStarted Dec 2005

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +20 more locations

TERMINATEDPhase 442 miles

Comparison of Absorbable Sutures in Perineal Laceration Repair

NCT00223119

The purpose of this study is to determine the difference in pain scales between absorbable suture types for second-degree perineal laceration repair.

Perineal Laceration Repair

Medtronic - MITGStarted Jan 2004

Norwalk, Connecticut, United States

COMPLETEDPhase 248 miles

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

NCT00001039

To assess the feasibility of using culture and staining techniques to quantify tissue Mycobacterium avium Complex (MAC) burden in bone marrow. To correlate and compare changes in MAC bone marrow burden with quantitative MAC blood culture results at baseline and after 4 and 8 weeks of treatment. MAC is easiest to detect in the blood, although doctors generally believe that MAC in blood is just "spill-over" from infection of other parts of the body. Traditionally, studies of potential treatments for MAC focus only on MAC changes in the blood. This study compares MAC changes in blood to those in bone marrow, which is another tissue where MAC is often found.

Mycobacterium Avium-intracellulare InfectionHIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)24 participants

Tucson, Arizona, United States • Baltimore, Maryland, United States • Camden, New Jersey, United States +5 more locations

TERMINATEDPhase 470 miles

Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

NCT00796705

Rheumatoid Arthritis (RA) is a systemic inflammatory autoimmune disorder that leads to inflammation and progressive joint damage affecting 2.5 million people in the United States. The primary purpose of this study is to determine the effectiveness of switching to an alternative Tumor Necrosis Factor (TNF) alpha inhibitor in comparison to continuing treatment with an existing TNF-alpha inhibitor in adults suffering from RA in a setting of inadequate clinical response to etanercept or adalimumab.

Rheumatoid Arthritis

National Institute of Allergy and Infectious Diseases (NIAID)13 participantsStarted Nov 2008

Birmingham, Alabama, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +13 more locations

COMPLETEDNA190 miles

Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura

NCT01713855

The purpose of this study is to determine how children with a history of severe, chronic Idiopathic Thrombocytopenic Purpura (ITP) who were treated with rituximab might respond to vaccines. Eligible patients are previously or currently enrolled in a study entitled "Open Label, Phase I/II Trial of Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura in Children and Adolescents" and have decided to obtain an inactivated influenza vaccination. These patients will be invited to provide one blood sample prior to vaccination and a second sample following vaccination to quantify immune response to vaccination.

Idiopathic Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura

Neufeld, Ellis J, MD, PhD10 participantsStarted Oct 2004

Los Angeles, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States

PreviousPage 170 of 180Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia